Please use this identifier to cite or link to this item:
Title: Controlled release of heparin from poly(ε-caprolactone) electrospun fibers
Authors: Luong-Van, E.
Grøndahl, L.
Chua, K.N.
Leong, K.W.
Nurcombe, V.
Cool, S.M. 
Keywords: Drug release
Pro-inflammatory response
Vascular smooth muscle cells
Issue Date: Mar-2006
Citation: Luong-Van, E., Grøndahl, L., Chua, K.N., Leong, K.W., Nurcombe, V., Cool, S.M. (2006-03). Controlled release of heparin from poly(ε-caprolactone) electrospun fibers. Biomaterials 27 (9) : 2042-2050. ScholarBank@NUS Repository.
Abstract: Sustained delivery of heparin to the localized adventitial surface of grafted blood vessels has been shown to prevent the vascular smooth muscle cell (VSMC) proliferation that can lead to graft occlusion and failure. In this study heparin was incorporated into electrospun poly(ε-caprolactone) (PCL) fiber mats for assessment as a controlled delivery device. Fibers with smooth surfaces and no bead defects could be spun from polymer solutions with 8% w/v PCL in 7:3 dichloromethane:methanol. A significant decrease in fiber diameter was observed with increasing heparin concentration. Assessment of drug loading, and imaging of fluorescently labeled heparin showed homogenous distribution of heparin throughout the fiber mats. A total of approximately half of the encapsulated heparin was released by diffusional control from the heparin/PCL fibers after 14 days. The fibers did not induce an inflammatory response in macrophage cells in vitro and the released heparin was effective in preventing the proliferation of VSMCs in culture. These results suggest that electrospun PCL fibers are a promising candidate for delivery of heparin to the site of vascular injury. © 2005 Elsevier Ltd. All rights reserved.
Source Title: Biomaterials
ISSN: 01429612
DOI: 10.1016/j.biomaterials.2005.10.028
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.